AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE in Zimbabwe
13 products registered with MCAZ β 13 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2019/7.13/5885 | HETERO LABS LTD | active | 8 Dec 2030 |
| DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2019/7.13/5834 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | 1 May 2029 |
| DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2020/7.13/5992 | MACLEODS PHARMACEUTICALS LIMITED | active | 10 Apr 2029 |
| DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL | 2019/7.13/5803 | LAURUS LABS LIMITED | active | 14 Mar 2029 |
| DOLUTEGRAVIR(SODIUM); LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2024/7.13/6548 | LUPIN LIMITED | active | 24 Jan 2029 |
| ACRIPTEGA TABLET, COATED; ORAL | 2018/7.13/5737 | MYLAN LABORATORIES LIMITED | active | 13 Nov 2028 |
| DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL TABLET, COATED; ORAL | 2018/7.13/5698 | AUROBINDO PHARMA LIMITED | active | 31 Dec 2027 |
| DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2019/7.13/5910 | CIPLA LTD | active | 31 Dec 2027 |
| DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED; ORAL | 2021/7.13/6127 | CIPLA QUALITY CHEMICAL INDUSTRIES LIMITED | active | 31 Dec 2027 |
| NONE TABLET, COATED; ORAL | 2025/7.13/7267 | CIPLA LTD | active | 31 Dec 2027 |
| TENOFOVIR DISOPROXIL FUMARATE; LAMIVUDINE; DOLUTEGRAVIR TABLET, COATED; ORAL | 2020/7.13/6065 | STRIDES SHASUN LIMITED | active | 31 Dec 2027 |
| DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMERATE TABLET; ORAL | 2024/7.13/6609 | SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD | active | 31 Dec 2027 |
| VIROPIL TABLET, COATED; ORAL | 2021/7.13/6115 | EMCURE PHARMACEUTICALS LTD | active | 31 Dec 2027 |
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE β MCAZ Registration Details
MCAZ (Zimbabwe) has 13 registered products containing DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE, of which 13 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.